Published in Biochim Biophys Acta on January 02, 2009
Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell (2010) 3.72
Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells. Mol Hum Reprod (2010) 1.06
Inhibitory phosphorylation of cyclin-dependent kinase 1 as a compensatory mechanism for mitosis exit. Mol Cell Biol (2011) 0.96
Phospho-Bcl-x(L)(Ser62) plays a key role at DNA damage-induced G(2) checkpoint. Cell Cycle (2012) 0.95
Positive-feedback loops in cell cycle progression. FEBS Lett (2009) 0.90
Feedback loops and reciprocal regulation: recurring motifs in the systems biology of the cell cycle. Curr Opin Cell Biol (2013) 0.89
Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe. Oncotarget (2015) 0.85
Multiple requirements of PLK1 during mouse oocyte maturation. PLoS One (2015) 0.81
Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents. Biochem J (2012) 0.81
Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice. Cell Cycle (2010) 0.80
Distinct pools of cdc25C are phosphorylated on specific TP sites and differentially localized in human mitotic cells. PLoS One (2010) 0.80
Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies. Mol Cell Biochem (2016) 0.80
Ser149 is another potential PKA phosphorylation target of Cdc25B in G2/M transition of fertilized mouse eggs. J Biol Chem (2011) 0.79
Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell lines. PLoS One (2014) 0.78
Polo kinase regulates the localization and activity of the chromosomal passenger complex in meiosis and mitosis in Drosophila melanogaster. Open Biol (2014) 0.78
CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer (2007) 3.46
The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett (2002) 2.30
The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol (2006) 2.28
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients. Arthritis Rheumatol (2015) 1.98
Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. J Cell Sci (2004) 1.93
53BP1 exchanges slowly at the sites of DNA damage and appears to require RNA for its association with chromatin. J Cell Sci (2005) 1.62
Pharmacological inhibition of aurora-A but not aurora-B impairs interphase microtubule dynamics. Cell Cycle (2009) 1.48
The cell cycle regulator CDC25A is a target for JAK2V617F oncogene. Blood (2011) 1.47
3D imaging of the response to CDC25 inhibition in multicellular spheroids. Cancer Biol Ther (2009) 1.45
Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1. J Cell Biol (2009) 1.41
Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer. BMC Cancer (2012) 1.28
The AT-hook protein D1 is essential for Drosophila melanogaster development and is implicated in position-effect variegation. Mol Cell Biol (2002) 1.26
Cell cycle control by the CDC25 phosphatases. Anticancer Agents Med Chem (2008) 1.22
OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol (2009) 1.19
CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage. Cell Cycle (2005) 1.18
CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. J Cell Sci (2006) 1.16
Molecular and functional characterization of SLC26A11, a sodium-independent sulfate transporter from high endothelial venules. FASEB J (2003) 1.13
Live cell division dynamics monitoring in 3D large spheroid tumor models using light sheet microscopy. Cell Div (2011) 1.12
Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation. Oncogene (2002) 1.11
CDC25B involvement in the centrosome duplication cycle and in microtubule nucleation. Cancer Res (2007) 1.06
Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation (2003) 1.04
Constitutive activation of the DNA damage signaling pathway in acute myeloid leukemia with complex karyotype: potential importance for checkpoint targeting therapy. Cancer Res (2009) 1.03
Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity. Bioorg Med Chem (2005) 1.03
Interaction of p21(CDKN1A) with PCNA regulates the histone acetyltransferase activity of p300 in nucleotide excision repair. Nucleic Acids Res (2008) 1.01
Protein kinase CK2 regulates CDC25B phosphatase activity. Oncogene (2003) 1.00
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression. Mol Cancer Ther (2006) 0.99
TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine (2011) 0.96
Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D. BMC Cancer (2013) 0.95
Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors. J Chem Inf Model (2007) 0.94
What's new on CDC25 phosphatase inhibitors. Pharmacol Ther (2007) 0.94
CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis. Cell Cycle (2005) 0.94
p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition. Cell Cycle (2003) 0.93
Characterization of the antiproliferative activity of Xylopia aethiopica. Cell Div (2012) 0.92
Moderate variations in CDC25B protein levels modulate the response to DNA damaging agents. Cell Cycle (2008) 0.92
Deep and clear optical imaging of thick inhomogeneous samples. PLoS One (2012) 0.91
CDC25B phosphorylation by p38 and MK-2. Cell Cycle (2006) 0.91
Distinct pools of proliferating cell nuclear antigen associated to DNA replication sites interact with the p125 subunit of DNA polymerase delta or DNA ligase I. Exp Cell Res (2004) 0.90
Identification of an unexpected link between the Shh pathway and a G2/M regulator, the phosphatase CDC25B. Dev Biol (2006) 0.90
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases. Mol Cancer Ther (2005) 0.89
Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra. Dermatology (2014) 0.88
IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells. Int J Cancer (2009) 0.88
Linking PCNA-dependent replication and ATR by human Claspin. Biochem Biophys Res Commun (2007) 0.88
Mechanical stress impairs mitosis progression in multi-cellular tumor spheroids. PLoS One (2013) 0.88
A screen for deubiquitinating enzymes involved in the G₂/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability. Cell Cycle (2010) 0.87
Inhibitors of the CDC25 phosphatases. Prog Cell Cycle Res (2003) 0.87
Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo. Cancer Res (2010) 0.87
Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage. Mol Cancer (2010) 0.87
Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. Eur J Dermatol (2005) 0.86
The CDC25B phosphatase shortens the G2 phase of neural progenitors and promotes efficient neuron production. Development (2012) 0.86
Nuclear localization of CDC25B1 and serine 146 integrity are required for induction of mitosis. J Biol Chem (2002) 0.85
Prognostic factors of paraneoplastic pemphigus. Arch Dermatol (2012) 0.85
Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C. Bioorg Med Chem Lett (2005) 0.84
Asymmetric localization of the CDC25B phosphatase to the mother centrosome during interphase. Cell Cycle (2007) 0.84
Molecular cloning of SLC26A7, a novel member of the SLC26 sulfate/anion transporter family, from high endothelial venules and kidney. Genomics (2002) 0.84
A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res (2004) 0.83
Evaluation of checkpoint kinase targeting therapy in acute myeloid leukemia with complex karyotype. Cancer Biol Ther (2012) 0.83
Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia. Eur J Pharmacol (2008) 0.83
Mitotic phosphorylation of Cdc25B Ser321 disrupts 14-3-3 binding to the high affinity Ser323 site. J Biol Chem (2010) 0.83
CDC25B overexpression stabilises centrin 2 and promotes the formation of excess centriolar foci. PLoS One (2013) 0.83
Pharmacologic inhibition of CDC25 phosphatases impairs interphase microtubule dynamics and mitotic spindle assembly. Mol Cancer Ther (2007) 0.82
NanoLC-MS/MS analysis provides new insights into the phosphorylation pattern of Cdc25B in vivo: full overlap with sites of phosphorylation by Chk1 and Cdk1/cycB kinases in vitro. J Proteome Res (2008) 0.82
Skin cancers after liver transplantation: retrospective single-center study on 371 recipients. Transplantation (2014) 0.81
A versatile sample holder for single plane illumination microscopy. J Microsc (2013) 0.80
PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation. Biol Cell (2003) 0.80
Phosphorylation of CDC25C at S263 controls its intracellular localisation. FEBS Lett (2007) 0.80
Identification of N-terminally truncated stable nuclear isoforms of CDC25B that are specifically involved in G2/M checkpoint recovery. Cancer Res (2011) 0.79
UV-induced downregulation of the CDC25B protein in human cells. FEBS Lett (2010) 0.79
Human CDC25B and CDC25C differ by their ability to restore a functional checkpoint response after gene replacement in fission yeast. Biochem Biophys Res Commun (2002) 0.78
Study of the docking-dependent PLK1 phosphorylation of the CDC25B phosphatase. Biochem Biophys Res Commun (2011) 0.78
[Bacterial cyclostatin, or how do bacteria manipulate the eukaryotic cell cycle]. Med Sci (Paris) (2003) 0.78
CDC25B associates with a centrin 2-containing complex and is involved in maintaining centrosome integrity. Biol Cell (2011) 0.78
Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia. Cancer Res (2006) 0.78
LIM-only protein FHL3 interacts with CDC25B2 phosphatase. Exp Cell Res (2003) 0.78
A new mitotic-cell specific monoclonal antibody. Cell Cycle (2007) 0.78
Evolutionary conservation of a novel splice variant of the Cds1/CHK2 checkpoint kinase restricted to its regulatory domain. Cell Cycle (2004) 0.78
Factors associated with 2009 monovalent H1N1 vaccine coverage: a cross sectional study of 1,308 patients with psoriasis in France. Vaccine (2012) 0.77
Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties. Bioorg Med Chem (2008) 0.77
What similarity between human and fission yeast proteins is required for orthology? Yeast (2002) 0.77
Synthesis of small molecule CDC25 phosphatases inhibitors. Bioorg Med Chem Lett (2004) 0.76
Microdevice arrays of high aspect ratio poly(dimethylsiloxane) pillars for the investigation of multicellular tumour spheroid mechanical properties. Lab Chip (2014) 0.76
Structure Tensor Based Analysis of Cells and Nuclei Organization in Tissues. IEEE Trans Med Imaging (2015) 0.76
Ability of human CDC25B phosphatase splice variants to replace the function of the fission yeast Cdc25 cell cycle regulator. FEMS Yeast Res (2004) 0.76
The "starter" and "gas pedal" of mitosis reside at the centrosome. Commentary on "characterization of centrosomal localization and dynamics of CDC25C phosphatase in mitosis" by Bonnet et al. Cell Cycle (2008) 0.75
Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide. Eur J Med Chem (2012) 0.75
A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25. Curr Genet (2004) 0.75
Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors. ChemMedChem (2009) 0.75
Risk of Aggressive Skin Cancers Following Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 Cases. Transplantation (2017) 0.75
5-Substituted [1]pyrindine derivatives with antiproliferative activity. Eur J Med Chem (2009) 0.75
Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cells. Development (2016) 0.75
Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatology. Eur J Dermatol (2008) 0.75
[The psoriatic continuum: a new concept]. Ann Dermatol Venereol (2011) 0.75